Zynyz (retifanlimab) is a late entrant to the PD-1/PD-L1 category, but picked up its first approval in the rare tumour Merkel cell carcinoma last ... in the control arm to cross over to ...

Bilen et al. perform a phase 2 single-arm clinical trial of neoadjuvant cabozantinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma, assess efficacy and find ...

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.

March 18, 2025: There’s a new Arm Wrestle Simulator code in to celebrate the release of the Superhero update. What are the new Arm Wrestle Simulator codes? This popular Roblox experience ...

Shares of semiconductor and technology names were mostly bouncing back today, with chip leaders Micron Technology (NASDAQ: MU), Lam Research (NASDAQ: LRCX), and Arm Holdings (NASDAQ: ARM ...

Explore ARM Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ARM. Slowdown And Tariff Talk Grips The Hottest Sector On Wall Street ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

A cell therapy is a medicinal product containing cells, and is typically injected into a patient. Examples include bone marrow transplants (also known as haematopoietic stem cell transplantation ...